AdvaMed CEO Scott Whitaker listed tariffs, user fees, reimbursement predictability and strengthening cybersecurity as his top ...

Office of Dietary Supplement Programs announces availability of “New Dietary Ingredient (NDI) Notifications and Related ...

Chief global commercialization officer Anthony Mancini talked to Scrip about why the company is building a commercial ...

Proposals for a regulatory sandbox system in Brazil were informed by experiences in other countries, and a pilot involving ...

Fractyl’s Revita met the six-month co-primary endpoint in the 308-patient REMAIN-1 pivotal study, and a De Novo request is ...

What's happening, why it matters and what's next at FDA. This edition explores the agency's approval of Alcon's Brytly ...

Medicines For Europe has suggested that the Netherlands’ proposal to transpose the Urban Waste Water Treatment Directive ...

The UK agency confirms an AI center, early access scheme and PCCPs in a push for more adaptive regulation – but industry ...

Among other executive moves are two Roche departures, to Oak Hill Bio and Pharmanovia, and three Moderna departures, to ...

Today marks the start of Global Biosimilars Week 2026, the latest instalment of the annual campaign from the IGBA that this ...

Menarini CEO Elcin Barker Ergun kept Stemline intact, licensed an obesity drug and, with NewAmsterdam, secured the first ...

Late-breaking data from novel cancer vaccines to next-generation KRAS G12C inhibitors and new antibody-drug conjugates will ...